Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Mouse Siglec-2/CD22 Antibody, R&D Systems™

Rat Monoclonal Antibody
Supplier: R&D Systems MAB2296SP
This item is not returnable.
View return policy
Description
Siglec-2/CD22 Monoclonal specifically detects Siglec-2/CD22 in Mouse samples. It is validated for Western Blot, Flow Cytometry, CyTOF-ready.Specifications
Siglec-2/CD22 | |
Monoclonal | |
LYOPH | |
Western Blot 1 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, CyTOF-ready | |
B-cell receptor CD22, BL-CAM, B-lymphocyte cell adhesion molecule, CD22, CD22 antigenMGC130020, CD22 molecule, sialic acid binding Ig-like lectin 2, Sialic acid-binding Ig-like lectin 2, Siglec2, SIGLEC-2, SIGLEC2FLJ22814, T-cell surface antigen Leu-14 | |
Rat | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
933 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2a |
Western Blot, Flow Cytometry, CyTOF | |
308501 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
Cd22 | |
Mouse myeloma cell line NS0-derived recombinant mouse Siglec-2/CD22 | |
25 μg | |
Primary | |
Detects mouse Siglec-2/CD22 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human Siglec-2, -3, -5, -6, -7, -9, -10, -11, or recombinant mouse Siglec-F is observed. | |
Mouse | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction